Additionally, compared with untreated cells, HCC cells treated with the GSK-3β inhibitor only expressed high levels of OPN and nuclear β-catenin expression, revealing a role for GSK3β inhibition in regulating OPN expression. The gene discussed is SPP1; the disease is hepatocellular carcinoma.